PT Sarana Meditama Metropolitan Tbk

Equities

SAME

ID1000126303

Healthcare Facilities & Services

End-of-day quote INDONESIA S.E. Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
270 ^IDR	+3.05%		0.00%	-14.01%

04-29	PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT Elang Mahkota Teknologi Tbk acquired 71.9% stake in PT Sarana Meditama Metropolitan Tbk from PT Omni Health Care for approximately IDR 580 billion.

December 01, 2020

PT Elang Mahkota Teknologi Tbk (IDX:EMTK) acquired 71.9% stake in PT Sarana Meditama Metropolitan Tbk (IDX:SAME) from PT Omni Health Care for approximately IDR 580 billion on December 1, 2020. PT Elang Mahkota Teknologi Tbk acquired shares at an offer per share of IDR 137. Tjahjadi Bunjamin of Hiswara Bunjamin & Tandjung acted as legal advisor for PT Omni Health Care.

PT Elang Mahkota Teknologi Tbk (IDX:EMTK) completed the acquisition of 71.9% stake in PT Sarana Meditama Metropolitan Tbk (IDX:SAME) from PT Omni Health Care on December 1, 2020.

Latest news about PT Sarana Meditama Metropolitan Tbk

PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23	CI
PT Sarana Meditama Metropolitan Tbk(IDX:SAME) dropped from S&P Global BMI Index	18/09/23	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	27/07/23	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	10/08/22	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	04/04/22	CI
PT Sarana Meditama Metropolitan Tbk acquired a 13.84% stake in PT Kedoya Adyaraya Tbk for approximately IDR 220 million.	30/01/22	CI
PT Sarana Meditama Metropolitan Tbk acquired an additional 2.52% stake in PT Kedoya Adyaraya Tbk for IDR 40.2 billion.	26/12/21	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
PT Sarana Meditama Metropolitan Tbk(IDX:SAME) added to S&P Global BMI Index	20/09/21	CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	28/07/21	CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First quarter Ended March 31, 2021	28/04/21	CI
PT Elang Mahkota Teknologi Tbk made an offer to acquire the remaining 28.1% stake in PT Sarana Meditama Metropolitan Tbk from the shareholders for IDR 250 billion.	17/01/21	CI
PT Elang Mahkota Teknologi Tbk acquired 71.9% stake in PT Sarana Meditama Metropolitan Tbk from PT Omni Health Care for approximately IDR 580 billion.	01/12/20	CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2020	30/07/20	CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2020	26/06/20	CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2019	30/12/19	CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2019	31/07/19	CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2019	29/04/19	CI
PT Sarana Meditama Nusantara announced that it has received IDR 25 billion in funding from PT Sarana Meditama Metropolitan Tbk	30/12/16	CI

Chart PT Sarana Meditama Metropolitan Tbk

Duration

Period

Chart PT Sarana Meditama Metropolitan Tbk

More charts

Company Profile

PT Sarana Meditama Metropolitan Tbk is an Indonesia-based company primarily engaged in providing healthcare service by building and operating hospitals. The Company hospitals are operated under the brand name of EMC Healthcare. The Company's specialty centers include cardiovascular center; digestive and bariatric center, and fertility and laparoscopy center. EMC Healthcare consists of seven hospitals that provide health services, namely EMC Alam Sutera Hospital, EMC Cibitung Hospital, EMC Cikarang Hospital, EMC Pekayon Hospital, EMC Pulomas Hospital, EMC Tangerang Hospital, and EMC Sentul Hospital. The Company also operates Grha Kedoya Hospital and Grha MM2100 Hospital through subsidiary PT Kedoya Adyaraya Tbk. The Company's subsidiaries include PT Sarana Meditama International, PT Sarana Meditama Anugerah, PT Sarana Meditama Nusantara, PT Kurnia Sejahtera Utama, PT Elang Medika Corpora, PT Sentosa Indah Sejahtera, and PT Kedoya Adyaraya Tbk.

Sector

Healthcare Facilities & Services

Calendar

24/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
PT SARANA MEDITAMA METROPOLITAN TBK	-14.01%	285M
AIER EYE HOSPITAL GROUP CO., LTD.	-23.96%	15.44B
BANGKOK DUSIT MEDICAL SERVICES	-2.70%	11.7B
IHH HEALTHCARE	+2.65%	11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED	+2.48%	10.12B
ENCOMPASS HEALTH CORPORATION	+25.28%	8.42B
RAMSAY HEALTH CARE LIMITED	-7.87%	7.18B
THE ENSIGN GROUP, INC.	+6.74%	6.76B
MOUWASAT MEDICAL SERVICES COMPANY	+1.07%	6.08B
DALLAH HEALTHCARE COMPANY	-3.96%	4.33B

Hospitals, Clinics & Primary Care Services